BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 16, 2016

Total Value ($000): $404,119 (93.9% shares, 6.1% debt)

Holdings (32)

— BLUEPRINT MEDICINES CORP 11.8%

Value ($000) $47,657 Shares 2,640,251 Est. Cost $25.07 Unrealized —

— CONCERT PHARMACEUTICALS INC 9.3%

Value ($000) $37,638 Shares 2,755,318 Est. Cost $13.78 Unrealized —

CYTK CYTOKINETICS INC 7.6%

Value ($000) $30,602 Shares 4,340,729 Est. Cost $6.85 Unrealized +6.6%

— FORWARD PHARMA A/S 6.1%

Value ($000) $24,502 Shares 1,441,287 Est. Cost $20.85 Unrealized —

— ONCOTHYREON INC 5.9%

Value ($000) $23,875 Shares 18,799,368 Est. Cost $2.18 Unrealized —

— CTI BIOPHARMA CORP 5.9%

Value ($000) $23,805 Shares 44,796,940 Est. Cost $1.27 Unrealized —

— ARRAY BIOPHARMA INC 5.7%

Value ($000) $23,158 Shares 7,850,211 Est. Cost $4.32 Unrealized —

— EXELIXIS INC 5.6%

Value ($000) $22,723 Shares 22,822,778 Est. Cost $0.84 Unrealized —

— CHEMOCENTRYX INC 5.0%

Value ($000) $20,373 Shares 8,182,052 Est. Cost $8.96 Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 4.8%

Value ($000) $19,208 Shares 1,755,745 Est. Cost $10.04 Unrealized -17.9%

— VITAE PHARMACEUTICALS INC 3.4%

Value ($000) $13,850 Shares 2,089,014 Est. Cost $10.50 Unrealized —

— ONCOMED PHARMACEUTICALS INC 3.4%

Value ($000) $13,541 Shares 1,339,336 Est. Cost $18.86 Unrealized —

— ARQULE INC 3.1%

Value ($000) $12,629 Shares 7,893,324 Est. Cost $1.87 Unrealized —

XENE XENON PHARMACEUTICALS INC 3.1%

Value ($000) $12,411 Shares 1,775,572 Est. Cost $10.53 Unrealized -31.8%

— QLT INC 2.8%

Value ($000) $11,346 Shares 5,701,609 Est. Cost $3.61 Unrealized —

ESPR ESPERION THERAPEUTICS INC NE 2.5%

Value ($000) $10,261 Shares 606,801 Est. Cost $16.09 Unrealized 0.0%

— TOBIRA THERAPEUTICS INC 2.5%

Value ($000) $10,253 Shares 1,253,401 Est. Cost $16.80 Unrealized —

— CELATOR PHARMACEUTICALS INC 2.2%

Value ($000) $8,824 Shares 800,000 Est. Cost $11.03 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 1.9%

Value ($000) $7,819 Shares 606,138 Est. Cost $15.82 Unrealized -12.2%

— NIVALIS THERAPEUTICS INC 1.6%

Value ($000) $6,450 Shares 1,546,743 Est. Cost $6.93 Unrealized —

— GTX INC DEL 1.4%

Value ($000) $5,756 Shares 11,512,000 Est. Cost $0.72 Unrealized —

— PAIN THERAPEUTICS INC 1.2%

Value ($000) $4,794 Shares 2,149,913 Est. Cost $1.85 Unrealized —

— SUNESIS PHARMACEUTICALS INC 0.6%

Value ($000) $2,599 Shares 4,813,294 Est. Cost $0.85 Unrealized —

— LOXO ONCOLOGY INC 0.5%

Value ($000) $2,047 Shares 74,870 Est. Cost $14.62 Unrealized —

— ARRAY BIOPHARMA INC 0.5%

Value ($000) $2,025 Shares 2,500,000 Est. Cost $1.27 Unrealized —

— CATALYST BIOSCIENCES INC 0.4%

Value ($000) $1,631 Shares 970,948 Est. Cost $4.66 Unrealized —

GBIM GLOBEIMMUNE INC 0.3%

Value ($000) $1,355 Shares 657,653 Est. Cost $6.22 Unrealized -65.2%

— MAST THERAPEUTICS INC 0.3%

Value ($000) $1,013 Shares 3,696,961 Est. Cost $0.56 Unrealized —

— CALITHERA BIOSCIENCES INC 0.2%

Value ($000) $925 Shares 162,900 Est. Cost $5.43 Unrealized —

— BIOTA PHARMACEUTIALS INC 0.1%

Value ($000) $526 Shares 350,776 Est. Cost $6.11 Unrealized —

— IGNYTA INC 0.1%

Value ($000) $339 Shares 50,000 Est. Cost $6.78 Unrealized —

— NEPHROGENEX INC 0.0%

Value ($000) $184 Shares 392,156 Est. Cost $1.60 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	2,640,251	$47,657	11.8%	$25.07	—	COM	09627Y109
—	CONCERT PHARMACEUTICALS INC	2,755,318	$37,638	9.3%	$13.78	—	COM	206022105
CYTK	CYTOKINETICS INC	4,340,729	$30,602	7.6%	$6.85	+6.6%	COM NEW	23282W605
—	FORWARD PHARMA A/S	1,441,287	$24,502	6.1%	$20.85	—	SPONSORED ADR	34986J105
—	ONCOTHYREON INC	18,799,368	$23,875	5.9%	$2.18	—	COM	682324108
—	CTI BIOPHARMA CORP	44,796,940	$23,805	5.9%	$1.27	—	COM	12648L106
—	ARRAY BIOPHARMA INC	7,850,211	$23,158	5.7%	$4.32	—	COM	04269X105
—	EXELIXIS INC	22,822,778	$22,723	5.6%	$0.84	—	NOTE 4.250% 8/1	30161QAC8
—	CHEMOCENTRYX INC	8,182,052	$20,373	5.0%	$8.96	—	COM	16383L106
IRWD	IRONWOOD PHARMACEUTICALS INC	1,755,745	$19,208	4.8%	$10.04	-17.9%	COM CL A	46333X108
—	VITAE PHARMACEUTICALS INC	2,089,014	$13,850	3.4%	$10.50	—	COM	92847N103
—	ONCOMED PHARMACEUTICALS INC	1,339,336	$13,541	3.4%	$18.86	—	COM	68234X102
—	ARQULE INC	7,893,324	$12,629	3.1%	$1.87	—	COM	04269E107
XENE	XENON PHARMACEUTICALS INC	1,775,572	$12,411	3.1%	$10.53	-31.8%	COM	98420N105
—	QLT INC	5,701,609	$11,346	2.8%	$3.61	—	COM	746927102
ESPR	ESPERION THERAPEUTICS INC NE	606,801	$10,261	2.5%	$16.09	0.0%	COM	29664W105
—	TOBIRA THERAPEUTICS INC	1,253,401	$10,253	2.5%	$16.80	—	COM	88883P101
—	CELATOR PHARMACEUTICALS INC	800,000	$8,824	2.2%	$11.03	—	COM	15089R102
CTMX	CYTOMX THERAPEUTICS INC	606,138	$7,819	1.9%	$15.82	-12.2%	COM	23284F105
—	NIVALIS THERAPEUTICS INC	1,546,743	$6,450	1.6%	$6.93	—	COM	65481J109
—	GTX INC DEL	11,512,000	$5,756	1.4%	$0.72	—	COM	40052B108
—	PAIN THERAPEUTICS INC	2,149,913	$4,794	1.2%	$1.85	—	COM	69562K100
—	SUNESIS PHARMACEUTICALS INC	4,813,294	$2,599	0.6%	$0.85	—	COM NEW	867328601
—	LOXO ONCOLOGY INC	74,870	$2,047	0.5%	$14.62	—	COM	548862101
—	ARRAY BIOPHARMA INC	2,500,000	$2,025	0.5%	$1.27	—	NOTE 3.000% 6/0	04269XAA3
—	CATALYST BIOSCIENCES INC	970,948	$1,631	0.4%	$4.66	—	COM	14888D109
GBIM	GLOBEIMMUNE INC	657,653	$1,355	0.3%	$6.22	-65.2%	COM	37957B100
—	MAST THERAPEUTICS INC	3,696,961	$1,013	0.3%	$0.56	—	COM	576314108
—	CALITHERA BIOSCIENCES INC	162,900	$925	0.2%	$5.43	—	COM	13089P101
—	BIOTA PHARMACEUTIALS INC	350,776	$526	0.1%	$6.11	—	COM	090694100
—	IGNYTA INC	50,000	$339	0.1%	$6.78	—	COM	451731103
—	NEPHROGENEX INC	392,156	$184	0.0%	$1.60	—	COM	640667101